Photocoagulation for peripheral areas of nonperfusion to prevent the recurrence of diabetic macular edema after intravitreal injection of bevacizumab.
Not Applicable
- Conditions
- Diabetic macular edema
- Registration Number
- JPRN-UMIN000007566
- Lead Sponsor
- Department of Ophthalmology, Faculty of Medical Sciences, University of Fukui
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
History of ocular surgery, Ocular diseases except for diabetic macular edema.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Best corrected visual acuity at 6 months after the injection of bevacizumab.
- Secondary Outcome Measures
Name Time Method Central retinal thickness at 6 months after the injection of bevacizumab.